{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:02:40Z","timestamp":1787241760610,"version":"build-2736575974"},"reference-count":186,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.cellsig.2019.109497","type":"journal-article","created":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T13:19:27Z","timestamp":1575897567000},"page":"109497","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Proliferative signaling by ERBB proteins and RAF\/MEK\/ERK effectors in polycystic kidney disease"],"prefix":"10.1016","volume":"67","author":[{"given":"Mitchell I.","family":"Parker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna S.","family":"Nikonova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danlin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica A.","family":"Golemis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.cellsig.2019.109497_bb0005","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/ki.1987.121","article-title":"Cyst formation and growth in autosomal dominant polycystic kidney disease","volume":"31","author":"Grantham","year":"1987","journal-title":"Kidney Int."},{"issue":"15","key":"10.1016\/j.cellsig.2019.109497_bb0010","doi-asserted-by":"crossref","first-page":"6007","DOI":"10.1073\/pnas.86.15.6007","article-title":"Renal epithelial cyst formation and enlargement in vitro: dependence on cAMP","volume":"86","author":"Mangoo-Karim","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"14","key":"10.1016\/j.cellsig.2019.109497_bb0015","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1096\/fasebj.3.14.2480260","article-title":"Renal epithelial fluid secretion and cyst growth: the role of cyclic AMP","volume":"3","author":"Mangoo-Karim","year":"1989","journal-title":"FASEB J."},{"issue":"10","key":"10.1016\/j.cellsig.2019.109497_bb0020","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1681\/ASN.2018050493","article-title":"Prevalence estimates of polycystic kidney and liver disease by population sequencing","volume":"29","author":"Lanktree","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1\u20132","key":"10.1016\/j.cellsig.2019.109497_bb0025","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/pr.2013.191","article-title":"Pathophysiology of childhood polycystic kidney diseases: new insights into disease-specific therapy","volume":"75","author":"Sweeney","year":"2014","journal-title":"Pediatr. Res."},{"issue":"6","key":"10.1016\/j.cellsig.2019.109497_bb0030","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1172\/JCI72272","article-title":"Genetic mechanisms and signaling pathways in autosomal dominant polycystic kidney disease","volume":"124","author":"Harris","year":"2014","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.cellsig.2019.109497_bb0035","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1053\/j.ajkd.2015.07.037","article-title":"Autosomal dominant polycystic kidney disease: core curriculum 2016","volume":"67","author":"Chebib","year":"2016","journal-title":"Am. J. Kidney Dis."},{"issue":"9981","key":"10.1016\/j.cellsig.2019.109497_bb0040","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/S0140-6736(15)60907-2","article-title":"Autosomal dominant polycystic kidney disease: the changing face of clinical management","volume":"385","author":"Ong","year":"2015","journal-title":"Lancet (London, England)"},{"issue":"2","key":"10.1016\/j.cellsig.2019.109497_bb0045","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0272-6386(12)80507-5","article-title":"Polycystic kidney disease: neoplasia in disguise","volume":"15","author":"Grantham","year":"1990","journal-title":"Am. J. Kidney Dis."},{"issue":"2","key":"10.1016\/j.cellsig.2019.109497_bb0050","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/ki.2009.128","article-title":"Autosomal dominant polycystic kidney disease: the last 3 years","volume":"76","author":"Torres","year":"2009","journal-title":"Kidney Int."},{"issue":"9","key":"10.1016\/j.cellsig.2019.109497_bb0055","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/nrneph.2015.46","article-title":"The hallmarks of cancer: relevance to the pathogenesis of polycystic kidney disease","volume":"11","author":"Seeger-Nukpezah","year":"2015","journal-title":"Nat. Rev. Nephrol."},{"issue":"1","key":"10.1016\/j.cellsig.2019.109497_bb0060","first-page":"49","article-title":"In vitro experiments on the effects of mouse sarcomas 180 and 37 on the spinal and sympathetic ganglia of the chick embryo","volume":"14","author":"Levi-Montalcini","year":"1954","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.cellsig.2019.109497_bb0065","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/0012-1606(65)90005-9","article-title":"The stimulation of epidermal proliferation by a specific protein (EGF)","volume":"12","author":"Cohen","year":"1965","journal-title":"Dev. Biol."},{"key":"10.1016\/j.cellsig.2019.109497_bb0070","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1749-6632.1960.tb49963.x","article-title":"Effects of the extract of the mouse submaxillary salivary glands on the sympathetic system of mammals","volume":"85","author":"Levi-Montalcini","year":"1960","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"23","key":"10.1016\/j.cellsig.2019.109497_bb0075","doi-asserted-by":"crossref","first-page":"7612","DOI":"10.1016\/S0021-9258(19)44569-9","article-title":"The primary structure of epidermal growth factor","volume":"247","author":"Savage","year":"1972","journal-title":"J. Biol. Chem."},{"issue":"22","key":"10.1016\/j.cellsig.2019.109497_bb0080","doi-asserted-by":"crossref","first-page":"7669","DOI":"10.1016\/S0021-9258(19)43242-0","article-title":"Epidermal growth factor. Location of disulfide bonds","volume":"248","author":"Savage","year":"1973","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.cellsig.2019.109497_bb0085","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/0092-8674(83)90307-0","article-title":"The product of the avian erythroblastosis virus erbB locus is a glycoprotein","volume":"32","author":"Privalsky","year":"1983","journal-title":"Cell"},{"key":"10.1016\/j.cellsig.2019.109497_bb0090","first-page":"1","article-title":"A historical perspective of the EGF receptor and related systems","volume":"327","author":"Edwin","year":"2006","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.cellsig.2019.109497_bb0095","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1146\/annurev.pharmtox.44.101802.121440","article-title":"ErbB receptors: directing key signaling networks throughout life","volume":"44","author":"Holbro","year":"2004","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"1","key":"10.1016\/j.cellsig.2019.109497_bb0100","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ajpath.2013.04.005","article-title":"Sustained activation of EGFR triggers renal fibrogenesis after acute kidney injury","volume":"183","author":"Tang","year":"2013","journal-title":"Am. J. Pathol."},{"issue":"10","key":"10.1016\/j.cellsig.2019.109497_bb0105","doi-asserted-by":"crossref","first-page":"5276","DOI":"10.1128\/MCB.16.10.5276","article-title":"A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor\/neuregulin and epidermal growth factor","volume":"16","author":"Tzahar","year":"1996","journal-title":"Mol. Cell. Biol."},{"issue":"7","key":"10.1016\/j.cellsig.2019.109497_bb0110","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1093\/emboj\/16.7.1647","article-title":"ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling","volume":"16","author":"Graus-Porta","year":"1997","journal-title":"EMBO J."},{"issue":"15","key":"10.1016\/j.cellsig.2019.109497_bb0115","doi-asserted-by":"crossref","first-page":"8933","DOI":"10.1073\/pnas.1537685100","article-title":"The ErbB2\/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation","volume":"100","author":"Holbro","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.cellsig.2019.109497_bb0120","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S1097-2765(03)00350-2","article-title":"An open-and-shut case? Recent insights into the activation of EGF\/ErbB receptors","volume":"12","author":"Burgess","year":"2003","journal-title":"Mol. Cell"},{"issue":"7","key":"10.1016\/j.cellsig.2019.109497_bb0125","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.cell.2010.06.011","article-title":"Cell signaling by receptor tyrosine kinases","volume":"141","author":"Lemmon","year":"2010","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.cellsig.2019.109497_bb0130","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.bbadis.2006.04.006","article-title":"Inhibition of HER-2(neu\/ErbB2) restores normal function and structure to polycystic kidney disease (PKD) epithelia","volume":"1762","author":"Wilson","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"issue":"7","key":"10.1016\/j.cellsig.2019.109497_bb0135","first-page":"953","article-title":"Expression of the HER-2\/neu proto-oncogene in normal human adult and fetal tissues","volume":"5","author":"Press","year":"1990","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.cellsig.2019.109497_bb0140","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/ki.1996.94","article-title":"Expression of epidermal growth factor and its receptor in normal and diseased human kidney: an immunohistochemical and in situ hybridization study","volume":"49","author":"Gesualdo","year":"1996","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.cellsig.2019.109497_bb0145","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.yexcr.2008.08.005","article-title":"The role of the EGF family of ligands and receptors in renal development, physiology and pathophysiology","volume":"315","author":"Zeng","year":"2009","journal-title":"Exp. Cell Res."},{"issue":"6","key":"10.1016\/j.cellsig.2019.109497_bb0150","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1161\/HYPERTENSIONAHA.108.113860","article-title":"Epidermal growth factor receptor signaling in the kidney: key roles in physiology and disease","volume":"52","author":"Melenhorst","year":"2008","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.cellsig.2019.109497_bb0155","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a020768","article-title":"The EGFR family: not so prototypical receptor tyrosine kinases","volume":"6","author":"Lemmon","year":"2014","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"28","key":"10.1016\/j.cellsig.2019.109497_bb0160","doi-asserted-by":"crossref","first-page":"26592","DOI":"10.1074\/jbc.M502906200","article-title":"G protein coupling and second messenger generation are indispensable for metalloprotease-dependent, heparin-binding epidermal growth factor shedding through angiotensin II type-1 receptor","volume":"280","author":"Mifune","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"2 Pt 1","key":"10.1016\/j.cellsig.2019.109497_bb0165","first-page":"C487","article-title":"Abnormal polarization of EGF receptors and autocrine stimulation of cyst epithelial growth in human ADPKD","volume":"269","author":"Du","year":"1995","journal-title":"Am. J. Phys."},{"issue":"3","key":"10.1016\/j.cellsig.2019.109497_bb0170","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/jcp.21635","article-title":"The epidermal growth factor receptor ligands at a glance","volume":"218","author":"Schneider","year":"2009","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.cellsig.2019.109497_bb0175","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1021\/pr100556z","article-title":"Active metalloproteases of the A Disintegrin and Metalloprotease (ADAM) family: biological function and structure","volume":"10","author":"Klein","year":"2011","journal-title":"J. Proteome Res."},{"issue":"11","key":"10.1016\/j.cellsig.2019.109497_bb0180","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1007\/s00109-012-0902-3","article-title":"Polycystin-1 regulates amphiregulin expression through CREB and AP1 signalling: implications in ADPKD cell proliferation","volume":"90","author":"Aguiari","year":"2012","journal-title":"J. Mol. Med. (Berl)"},{"issue":"3\u20134","key":"10.1016\/j.cellsig.2019.109497_bb0185","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3109\/08977199609003220","article-title":"Human betacellulin, a member of the EGF family dominantly expressed in pancreas and small intestine, is fully active in a monomeric form","volume":"13","author":"Seno","year":"1996","journal-title":"Growth Factors"},{"issue":"8","key":"10.1016\/j.cellsig.2019.109497_bb0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023894","article-title":"Betacellulin-induced beta cell proliferation and regeneration is mediated by activation of ErbB-1 and ErbB-2 receptors","volume":"6","author":"Oh","year":"2011","journal-title":"PLoS One"},{"issue":"21","key":"10.1016\/j.cellsig.2019.109497_bb0195","doi-asserted-by":"crossref","first-page":"18265","DOI":"10.1074\/jbc.M006935200","article-title":"Cloning and biological activity of epigen, a novel member of the epidermal growth factor superfamily","volume":"276","author":"Strachan","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"45","key":"10.1016\/j.cellsig.2019.109497_bb0200","doi-asserted-by":"crossref","first-page":"32890","DOI":"10.1074\/jbc.M702677200","article-title":"Juxtacrine activation of epidermal growth factor (EGF) receptor by membrane-anchored heparin-binding EGF-like growth factor protects epithelial cells from anoikis while maintaining an epithelial phenotype","volume":"282","author":"Singh","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.cellsig.2019.109497_bb0205","doi-asserted-by":"crossref","DOI":"10.3390\/cancers9050052","article-title":"Epidermal growth factor receptor cell proliferation signaling pathways","volume":"9","author":"Wee","year":"2017","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.cellsig.2019.109497_bb0210","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/S0021-9258(19)40080-X","article-title":"Analysis of deletions of the carboxyl terminus of the epidermal growth factor receptor reveals self-phosphorylation at tyrosine 992 and enhanced in vivo tyrosine phosphorylation of cell substrates","volume":"265","author":"Walton","year":"1990","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.cellsig.2019.109497_bb0215","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a011254","article-title":"MAP kinase pathways","volume":"4","author":"Morrison","year":"2012","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.cellsig.2019.109497_bb0220","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0065-230X(08)60765-4","article-title":"Signal transduction through MAP kinase cascades","volume":"74","author":"Lewis","year":"1998","journal-title":"Adv. Cancer Res."},{"issue":"1","key":"10.1016\/j.cellsig.2019.109497_bb0225","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cell.2017.06.009","article-title":"RAS proteins and their regulators in human disease","volume":"170","author":"Simanshu","year":"2017","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.cellsig.2019.109497_bb0230","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/sj.ki.5002229","article-title":"Hyperproliferation of PKD1 cystic cells is induced by insulin-like growth factor-1 activation of the Ras\/Raf signalling system","volume":"72","author":"Parker","year":"2007","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.cellsig.2019.109497_bb0235","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.celrep.2014.10.010","article-title":"Complex relationship between ligand binding and dimerization in the epidermal growth factor receptor","volume":"9","author":"Bessman","year":"2014","journal-title":"Cell Rep."},{"issue":"45","key":"10.1016\/j.cellsig.2019.109497_bb0240","doi-asserted-by":"crossref","first-page":"38244","DOI":"10.1074\/jbc.M112.414391","article-title":"Mechanisms for kinase-mediated dimerization of the epidermal growth factor receptor","volume":"287","author":"Lu","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.cellsig.2019.109497_bb0245","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0092-8674(03)01077-8","article-title":"Specificity in signal transduction: from phosphotyrosine-SH2 domain interactions to complex cellular systems","volume":"116","author":"Pawson","year":"2004","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.cellsig.2019.109497_bb0250","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0092-8674(92)90167-B","article-title":"The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling","volume":"70","author":"Lowenstein","year":"1992","journal-title":"Cell"},{"issue":"5112","key":"10.1016\/j.cellsig.2019.109497_bb0255","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1126\/science.8493579","article-title":"Human Sos1: a guanine nucleotide exchange factor for Ras that binds to GRB2","volume":"260","author":"Chardin","year":"1993","journal-title":"Science (New York, N.Y.)"},{"issue":"6424","key":"10.1016\/j.cellsig.2019.109497_bb0260","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/363085a0","article-title":"Guanine-nucleotide-releasing factor hSos1 binds to Grb2 and links receptor tyrosine kinases to Ras signalling","volume":"363","author":"Li","year":"1993","journal-title":"Nature"},{"issue":"6424","key":"10.1016\/j.cellsig.2019.109497_bb0265","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/363045a0","article-title":"Association of Sos Ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformation","volume":"363","author":"Egan","year":"1993","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.cellsig.2019.109497_bb0270","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1093\/ndt\/gfh744","article-title":"Subcellular distribution of Ras GTPase isoforms in normal human kidney","volume":"20","author":"Kocher","year":"2005","journal-title":"Nephrol. Dial. Transplant."},{"issue":"5","key":"10.1016\/j.cellsig.2019.109497_bb0275","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/nsmb.1418","article-title":"Membrane-dependent signal integration by the Ras activator Son of sevenless","volume":"15","author":"Gureasko","year":"2008","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"6","key":"10.1016\/j.cellsig.2019.109497_bb0280","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1016\/S0021-9258(17)41718-2","article-title":"Interaction of Ras and Raf in intact mammalian cells upon extracellular stimulation","volume":"269","author":"Hallberg","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellsig.2019.109497_bb0285","first-page":"101","article-title":"Control of the ERK MAP kinase cascade by Ras and Raf","volume":"27","author":"Marais","year":"1996","journal-title":"Cancer Surv."},{"issue":"11","key":"10.1016\/j.cellsig.2019.109497_bb0290","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/35099076","article-title":"The ETS-domain transcription factor family","volume":"2","author":"Sharrocks","year":"2001","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.cellsig.2019.109497_bb0295","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0076-6879(05)07031-X","article-title":"Effects of Ras signaling on gene expression analyzed by customized microarrays","volume":"407","author":"Tchernitsa","year":"2006","journal-title":"Methods Enzymol."},{"issue":"1","key":"10.1016\/j.cellsig.2019.109497_bb0300","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/15216540210811","article-title":"Protein tyrosine phosphatases: dephosphorylating the epidermal growth factor receptor","volume":"53","author":"Tiganis","year":"2002","journal-title":"IUBMB Life"},{"issue":"2","key":"10.1016\/j.cellsig.2019.109497_bb0305","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.molcel.2016.12.004","article-title":"A global analysis of the receptor tyrosine kinase-protein phosphatase interactome","volume":"65","author":"Yao","year":"2017","journal-title":"Mol. Cell"},{"issue":"9","key":"10.1016\/j.cellsig.2019.109497_bb0310","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1158\/1078-0432.CCR-16-0934","article-title":"Molecular pathways: targeting protein tyrosine phosphatases in cancer","volume":"23","author":"Bollu","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.cellsig.2019.109497_bb0315","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.cell.2016.02.047","article-title":"The dark side of cell signaling: positive roles for negative regulators","volume":"164","author":"Lemmon","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.cellsig.2019.109497_bb0320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jbior.2014.04.002","article-title":"An expanding role for RAS GTPase activating proteins (RAS GAPs) in cancer","volume":"55","author":"Maertens","year":"2014","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.cellsig.2019.109497_bb0325","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.semcdb.2016.06.006","article-title":"New structural and functional insight into the regulation of Ras","volume":"58","author":"Kano","year":"2016","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.cellsig.2019.109497_bb0330","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.31993","article-title":"EGF receptor signaling, phosphorylation, ubiquitylation and endocytosis in tumors in vivo","volume":"6","author":"Pinilla-Macua","year":"2017","journal-title":"Elife"},{"issue":"6","key":"10.1016\/j.cellsig.2019.109497_bb0335","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/nrc1366","article-title":"A renaissance for SRC","volume":"4","author":"Yeatman","year":"2004","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"10.1016\/j.cellsig.2019.109497_bb0340","doi-asserted-by":"crossref","first-page":"F721","DOI":"10.1152\/ajprenal.00141.2017","article-title":"Src family kinases in chronic kidney disease","volume":"313","author":"Wang","year":"2017","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"12","key":"10.1016\/j.cellsig.2019.109497_bb0345","doi-asserted-by":"crossref","first-page":"8335","DOI":"10.1074\/jbc.274.12.8335","article-title":"c-Src-mediated phosphorylation of the epidermal growth factor receptor on Tyr845 and Tyr1101 is associated with modulation of receptor function","volume":"274","author":"Biscardi","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"24","key":"10.1016\/j.cellsig.2019.109497_bb0350","doi-asserted-by":"crossref","first-page":"17209","DOI":"10.1074\/jbc.274.24.17209","article-title":"ErbB receptor-induced activation of stat transcription factors is mediated by Src tyrosine kinases","volume":"274","author":"Olayioye","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.cellsig.2019.109497_bb0355","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/S0960-9822(96)00748-8","article-title":"The Shc adaptor protein is highly phosphorylated at conserved, twin tyrosine residues (Y239\/240) that mediate protein-protein interactions","volume":"6","author":"van der Geer","year":"1996","journal-title":"Curr. Biol."},{"issue":"3","key":"10.1016\/j.cellsig.2019.109497_bb0360","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.bbrc.2010.07.092","article-title":"RAF protein-serine\/threonine kinases: structure and regulation","volume":"399","author":"Roskoski","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"36","key":"10.1016\/j.cellsig.2019.109497_bb0365","doi-asserted-by":"crossref","first-page":"E3785","DOI":"10.1073\/pnas.1406559111","article-title":"Src promotes GTPase activity of Ras via tyrosine 32 phosphorylation","volume":"111","author":"Bunda","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"15","key":"10.1016\/j.cellsig.2019.109497_bb0370","doi-asserted-by":"crossref","first-page":"6981","DOI":"10.1073\/pnas.92.15.6981","article-title":"Potentiation of epidermal growth factor receptor-mediated oncogenesis by c-Src: implications for the etiology of multiple human cancers","volume":"92","author":"Maa","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/j.cellsig.2019.109497_bb0375","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/nrneph.2016.91","article-title":"The epidermal growth factor receptor pathway in chronic kidney diseases","volume":"12","author":"Harskamp","year":"2016","journal-title":"Nat. Rev. Nephrol."},{"issue":"2","key":"10.1016\/j.cellsig.2019.109497_bb0380","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/ki.1997.336","article-title":"Receptor protein tyrosine kinases in perinatal developing rat kidney","volume":"52","author":"Kee","year":"1997","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.cellsig.2019.109497_bb0385","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1681\/ASN.2011020160","article-title":"ErbB4 modulates tubular cell polarity and lumen diameter during kidney development","volume":"23","author":"Veikkolainen","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"issue":"2","key":"10.1016\/j.cellsig.2019.109497_bb0390","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1681\/ASN.V122379","article-title":"Segment-specific c-ErbB2 expression in human autosomal recessive polycystic kidney disease","volume":"12","author":"Nakanishi","year":"2001","journal-title":"J. Am. Soc. Nephrol."},{"issue":"5221","key":"10.1016\/j.cellsig.2019.109497_bb0395","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1126\/science.7618084","article-title":"Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype","volume":"269","author":"Threadgill","year":"1995","journal-title":"Science (New York, N.Y.)"},{"issue":"3 Pt 2","key":"10.1016\/j.cellsig.2019.109497_bb0400","first-page":"F463","article-title":"EGF receptor ligands are a large fraction of in vitro branching morphogens secreted by embryonic kidney","volume":"273","author":"Sakurai","year":"1997","journal-title":"Am. J. Phys."},{"issue":"6 Pt 2","key":"10.1016\/j.cellsig.2019.109497_bb0405","first-page":"F1103","article-title":"Growth factors and the kidney: regulation of epithelial cell movement and morphogenesis","volume":"271","author":"Cantley","year":"1996","journal-title":"Am. J. Phys."},{"issue":"9","key":"10.1016\/j.cellsig.2019.109497_bb0410","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1681\/ASN.2017121272","article-title":"EGF receptor-dependent YAP activation is important for renal recovery from AKI","volume":"29","author":"Chen","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.cellsig.2019.109497_bb0415","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0002-9440(10)63651-6","article-title":"Activation of Src kinase in platelet-derived growth factor-B-dependent tubular regeneration after acute ischemic renal injury","volume":"163","author":"Takikita-Suzuki","year":"2003","journal-title":"Am. J. Pathol."},{"issue":"5","key":"10.1016\/j.cellsig.2019.109497_bb0420","doi-asserted-by":"crossref","first-page":"F960","DOI":"10.1152\/ajprenal.00020.2006","article-title":"Upregulation of EphA2 during in vivo and in vitro renal ischemia-reperfusion injury: role of Src kinases","volume":"291","author":"Baldwin","year":"2006","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"5","key":"10.1016\/j.cellsig.2019.109497_bb0425","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1002\/jcp.22946","article-title":"Src family kinases regulate renal epithelial dedifferentiation through activation of EGFR\/PI3K signaling","volume":"227","author":"Zhuang","year":"2012","journal-title":"J. Cell. Physiol."},{"issue":"6","key":"10.1016\/j.cellsig.2019.109497_bb0430","doi-asserted-by":"crossref","first-page":"C554","DOI":"10.1152\/ajpcell.00188.2014","article-title":"Epidermal growth factor-induced proliferation of collecting duct cells from Oak Ridge polycystic kidney mice involves activation of Na+\/H+ exchanger","volume":"307","author":"Coaxum","year":"2014","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"2","key":"10.1016\/j.cellsig.2019.109497_bb0435","doi-asserted-by":"crossref","first-page":"F828","DOI":"10.1152\/ajprenal.00369.2006","article-title":"Control of tight junctional sealing: role of epidermal growth factor","volume":"292","author":"Flores-Benitez","year":"2007","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"5","key":"10.1016\/j.cellsig.2019.109497_bb0440","doi-asserted-by":"crossref","first-page":"C1660","DOI":"10.1152\/ajpcell.00274.2007","article-title":"Juxtacrine activation of EGFR regulates claudin expression and increases transepithelial resistance","volume":"293","author":"Singh","year":"2007","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"9","key":"10.1016\/j.cellsig.2019.109497_bb0445","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/ng.2715","article-title":"Loss of cilia suppresses cyst growth in genetic models of autosomal dominant polycystic kidney disease","volume":"45","author":"Ma","year":"2013","journal-title":"Nat. Genet."},{"issue":"6","key":"10.1016\/j.cellsig.2019.109497_bb0450","first-page":"457","article-title":"Histogenesis of the renal cysts in adult (autosomal dominant) polycystic kidney disease: a histochemical study","volume":"1","author":"Verani","year":"1988","journal-title":"Mod. Pathol."},{"issue":"5","key":"10.1016\/j.cellsig.2019.109497_bb0455","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.coph.2005.04.016","article-title":"Emerging therapies for polycystic kidney disease","volume":"5","author":"Gattone","year":"2005","journal-title":"Curr. Opin. Pharmacol."},{"issue":"1","key":"10.1016\/j.cellsig.2019.109497_bb0460","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1681\/ASN.2007060688","article-title":"Vasopressin directly regulates cyst growth in polycystic kidney disease","volume":"19","author":"Wang","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"issue":"4","key":"10.1016\/j.cellsig.2019.109497_bb0465","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1046\/j.1523-1755.2000.00991.x","article-title":"cAMP stimulates the in vitro proliferation of renal cyst epithelial cells by activating the extracellular signal-regulated kinase pathway","volume":"57","author":"Yamaguchi","year":"2000","journal-title":"Kidney Int."},{"issue":"6","key":"10.1016\/j.cellsig.2019.109497_bb0470","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1046\/j.1523-1755.2003.00023.x","article-title":"Cyclic AMP activates B-Raf and ERK in cyst epithelial cells from autosomal-dominant polycystic kidneys","volume":"63","author":"Yamaguchi","year":"2003","journal-title":"Kidney Int."},{"issue":"39","key":"10.1016\/j.cellsig.2019.109497_bb0475","doi-asserted-by":"crossref","first-page":"40419","DOI":"10.1074\/jbc.M405079200","article-title":"Calcium restriction allows cAMP activation of the B-Raf\/ERK pathway, switching cells to a cAMP-dependent growth-stimulated phenotype","volume":"279","author":"Yamaguchi","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.cellsig.2019.109497_bb0480","doi-asserted-by":"crossref","first-page":"F944","DOI":"10.1152\/ajprenal.00387.2010","article-title":"Sorafenib inhibits cAMP-dependent ERK activation, cell proliferation, and in vitro cyst growth of human ADPKD cyst epithelial cells","volume":"299","author":"Yamaguchi","year":"2010","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"1","key":"10.1016\/j.cellsig.2019.109497_bb0485","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1681\/ASN.2013040398","article-title":"Strategies targeting cAMP signaling in the treatment of polycystic kidney disease","volume":"25","author":"Torres","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cellsig.2019.109497_bb0490","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ceca.2017.05.011","article-title":"Polycystin and calcium signaling in cell death and survival","volume":"69","author":"Lemos","year":"2018","journal-title":"Cell Calcium"},{"issue":"10","key":"10.1016\/j.cellsig.2019.109497_bb0495","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.bbadis.2010.11.005","article-title":"Cyclic AMP-mediated cyst expansion","volume":"1812","author":"Wallace","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cellsig.2019.109497_bb0500","series-title":"Polycystic Kidney Disease","article-title":"The role of calcium and cyclic AMP in PKD","author":"Calvet","year":"2015"},{"issue":"15","key":"10.1016\/j.cellsig.2019.109497_bb0505","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1091\/mbc.e09-12-1059","article-title":"Autosomal recessive polycystic kidney disease epithelial cell model reveals multiple basolateral epidermal growth factor receptor sorting pathways","volume":"21","author":"Ryan","year":"2010","journal-title":"Mol. Biol. Cell"},{"issue":"10","key":"10.1016\/j.cellsig.2019.109497_bb0510","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.bbadis.2011.05.008","article-title":"Apico-basal polarity in polycystic kidney disease epithelia","volume":"1812","author":"Wilson","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.cellsig.2019.109497_bb0515","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/1878-0261.12155","article-title":"Emerging functions of the EGFR in cancer","volume":"12","author":"Sigismund","year":"2018","journal-title":"Mol. Oncol."},{"issue":"1","key":"10.1016\/j.cellsig.2019.109497_bb0520","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/ki.1991.7","article-title":"Epidermal growth factor (EGF) expression in the congenital polycystic mouse kidney","volume":"39","author":"Horikoshi","year":"1991","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.cellsig.2019.109497_bb0525","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0272-6386(12)70198-1","article-title":"Expression of differentiation antigens and growth-related genes in normal kidney, autosomal dominant polycystic kidney disease, and renal cell carcinoma","volume":"19","author":"Klingel","year":"1992","journal-title":"Am. J. Kidney Dis."},{"issue":"2","key":"10.1016\/j.cellsig.2019.109497_bb0530","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/ki.1995.62","article-title":"Epidermal growth factor receptor expression is abnormal in murine polycystic kidney","volume":"47","author":"Orellana","year":"1995","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.cellsig.2019.109497_bb0535","first-page":"131","article-title":"Autocrine, endocrine and paracrine regulation of growth abnormalities in autosomal dominant polycystic kidney disease","volume":"61","author":"Wilson","year":"1993","journal-title":"Eur. J. Cell Biol."},{"issue":"1","key":"10.1016\/j.cellsig.2019.109497_bb0540","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1083\/jcb.149.1.111","article-title":"Compromised cytoarchitecture and polarized trafficking in autosomal dominant polycystic kidney disease cells","volume":"149","author":"Charron","year":"2000","journal-title":"J. Cell Biol."},{"issue":"3","key":"10.1016\/j.cellsig.2019.109497_bb0545","doi-asserted-by":"crossref","first-page":"F474","DOI":"10.1152\/ajprenal.00227.2004","article-title":"Abnormal EGF-dependent regulation of sodium absorption in ARPKD collecting duct cells","volume":"288","author":"Veizis","year":"2005","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"5","key":"10.1016\/j.cellsig.2019.109497_bb0550","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1172\/JCI2071","article-title":"Epidermal growth factor receptor activity mediates renal cyst formation in polycystic kidney disease","volume":"101","author":"Richards","year":"1998","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.cellsig.2019.109497_bb0555","first-page":"F387","article-title":"Functional activity of epidermal growth factor receptors in autosomal recessive polycystic kidney disease","volume":"275","author":"Sweeney","year":"1998","journal-title":"Am. J. Phys."},{"issue":"6","key":"10.1016\/j.cellsig.2019.109497_bb0560","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1111\/j.1523-1755.2004.00623.x","article-title":"EGF-related growth factors in the pathogenesis of murine ARPKD","volume":"65","author":"MacRae Dell","year":"2004","journal-title":"Kidney Int."},{"issue":"10","key":"10.1016\/j.cellsig.2019.109497_bb0565","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.bbadis.2010.10.004","article-title":"Epidermal growth factor-mediated proliferation and sodium transport in normal and PKD epithelial cells","volume":"1812","author":"Zheleznova","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cellsig.2019.109497_bb0570","first-page":"48","article-title":"Epidermal growth factor promotes cyst formation by human renal epithelial cells in vitro","volume":"103","author":"Neufeld","year":"1990","journal-title":"Trans. Assoc. Am. Phys."},{"issue":"1","key":"10.1016\/j.cellsig.2019.109497_bb0575","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0022-5347(01)64084-9","article-title":"Expression of transforming growth factor alpha and epidermal growth factor receptor in adult polycystic kidney disease","volume":"159","author":"Lee","year":"1998","journal-title":"J. Urol."},{"issue":"2","key":"10.1016\/j.cellsig.2019.109497_bb0580","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S0022-2143(96)90081-5","article-title":"Renal expression of a transforming growth factor-\u03b1 transgene accelerates the progression of inherited, slowly progressive polycystic kidney disease in the mouse","volume":"127","author":"Gattone","year":"1996","journal-title":"J. Lab. Clin. Med."},{"issue":"3","key":"10.1016\/j.cellsig.2019.109497_bb0585","first-page":"386","article-title":"Renal cysts in transgenic mice expressing transforming growth factor-alpha","volume":"124","author":"Lowden","year":"1994","journal-title":"J. Lab. Clin. Med."},{"issue":"5","key":"10.1016\/j.cellsig.2019.109497_bb0590","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1046\/j.1523-1755.2003.00256.x","article-title":"EGF receptor tyrosine kinase inhibition attenuates the development of PKD in Han:SPRD rats","volume":"64","author":"Torres","year":"2003","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/j.cellsig.2019.109497_bb0595","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/ki.1991.239","article-title":"C-erb B-2 amplification in cystic renal disease","volume":"40","author":"Herrera","year":"1991","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/j.cellsig.2019.109497_bb0600","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/ki.2014.84","article-title":"Deletion of ErbB4 accelerates polycystic kidney disease progression in cpk mice","volume":"86","author":"Zeng","year":"2014","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.cellsig.2019.109497_bb0605","doi-asserted-by":"crossref","first-page":"F577","DOI":"10.1152\/ajprenal.00607.2016","article-title":"Parallel microarray profiling identifies ErbB4 as a determinant of cyst growth in ADPKD and a prognostic biomarker for disease progression","volume":"312","author":"Streets","year":"2017","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"10","key":"10.1016\/j.cellsig.2019.109497_bb0610","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.2215\/CJN.09941014","article-title":"Urinary EGF receptor ligand excretion in patients with autosomal dominant polycystic kidney disease and response to tolvaptan","volume":"10","author":"Harskamp","year":"2015","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"13","key":"10.1016\/j.cellsig.2019.109497_bb0615","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1093\/hmg\/ddp165","article-title":"Systems biology of autosomal dominant polycystic kidney disease (ADPKD): computational identification of gene expression pathways and integrated regulatory networks","volume":"18","author":"Song","year":"2009","journal-title":"Hum. Mol. Genet."},{"issue":"4","key":"10.1016\/j.cellsig.2019.109497_bb0620","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nrg3185","article-title":"Insights into the regulation of protein abundance from proteomic and transcriptomic analyses","volume":"13","author":"Vogel","year":"2012","journal-title":"Nat. Rev. Genet."},{"issue":"4 Pt 2","key":"10.1016\/j.cellsig.2019.109497_bb0625","first-page":"F434","article-title":"Epithelial cell polarity and disease","volume":"272","author":"Wilson","year":"1997","journal-title":"Am. J. Phys."},{"issue":"9","key":"10.1016\/j.cellsig.2019.109497_bb0630","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0106330","article-title":"OFD1 and flotillins are integral components of a ciliary signaling protein complex organized by polycystins in renal epithelia and odontoblasts","volume":"9","author":"Jerman","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.cellsig.2019.109497_bb0635","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/jcp.1041620316","article-title":"Cytoplasmic juxtamembrane domain of the human EGF receptor is required for basolateral localization in MDCK cells","volume":"162","author":"Hobert","year":"1995","journal-title":"J. Cell. Physiol."},{"issue":"7","key":"10.1016\/j.cellsig.2019.109497_bb0640","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.cell.2007.04.035","article-title":"HEF1-dependent Aurora A activation induces disassembly of the primary cilium","volume":"129","author":"Pugacheva","year":"2007","journal-title":"Cell"},{"issue":"15","key":"10.1016\/j.cellsig.2019.109497_bb0645","doi-asserted-by":"crossref","first-page":"11219","DOI":"10.1074\/jbc.M109.042754","article-title":"The microtubule-associated histone deacetylase 6 (HDAC6) regulates epidermal growth factor receptor (EGFR) endocytic trafficking and degradation","volume":"285","author":"Gao","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.cellsig.2019.109497_bb0650","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0049418","article-title":"HDAC6 regulates epidermal growth factor receptor (EGFR) endocytic trafficking and degradation in renal epithelial cells","volume":"7","author":"Liu","year":"2012","journal-title":"PLoS One"},{"issue":"43","key":"10.1016\/j.cellsig.2019.109497_bb0655","doi-asserted-by":"crossref","first-page":"17897","DOI":"10.1074\/jbc.M117.803775","article-title":"Histone deacetylase 6 inhibition reduces cysts by decreasing cAMP and Ca(2+) in knock-out mouse models of polycystic kidney disease","volume":"292","author":"Yanda","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.cellsig.2019.109497_bb0660","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.kint.2016.01.026","article-title":"Inhibition of histone deacetylase 6 activity reduces cyst growth in polycystic kidney disease","volume":"90","author":"Cebotaru","year":"2016","journal-title":"Kidney Int."},{"issue":"18","key":"10.1016\/j.cellsig.2019.109497_bb0665","doi-asserted-by":"crossref","first-page":"8285","DOI":"10.1128\/MCB.25.18.8285-8298.2005","article-title":"PKD2 functions as an epidermal growth factor-activated plasma membrane channel","volume":"25","author":"Ma","year":"2005","journal-title":"Mol. Cell. Biol."},{"issue":"8","key":"10.1016\/j.cellsig.2019.109497_bb0670","article-title":"TRPP2 and TRPV4 form an EGF-activated calcium permeable channel at the apical membrane of renal collecting duct cells","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.cellsig.2019.109497_bb0675","doi-asserted-by":"crossref","first-page":"F541","DOI":"10.1152\/ajprenal.00273.2001","article-title":"Polaris, a protein disrupted in orpk mutant mice, is required for assembly of renal cilium","volume":"282","author":"Yoder","year":"2002","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"8","key":"10.1016\/j.cellsig.2019.109497_bb0680","doi-asserted-by":"crossref","first-page":"593","DOI":"10.5483\/BMBRep.2008.41.8.593","article-title":"NCAM as a cystogenesis marker gene of PKD2 overexpression","volume":"41","author":"Yoo","year":"2008","journal-title":"BMB Rep."},{"issue":"11","key":"10.1016\/j.cellsig.2019.109497_bb0685","doi-asserted-by":"crossref","first-page":"7214","DOI":"10.1074\/jbc.M805890200","article-title":"Cyst formation in kidney via B-Raf signaling in the PKD2 transgenic mice","volume":"284","author":"Park","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.cellsig.2019.109497_bb0690","doi-asserted-by":"crossref","first-page":"9975","DOI":"10.18632\/oncotarget.7198","article-title":"Identification of drugs that restore primary cilium expression in cancer cells","volume":"7","author":"Khan","year":"2016","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.cellsig.2019.109497_bb0695","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0160216","article-title":"Gefitinib, an EGFR tyrosine kinase inhibitor, prevents smoke-mediated ciliated airway epithelial cell loss and promotes their recovery","volume":"11","author":"Valencia-Gattas","year":"2016","journal-title":"PLoS One"},{"issue":"13","key":"10.1016\/j.cellsig.2019.109497_bb0700","doi-asserted-by":"crossref","first-page":"4179","DOI":"10.1158\/1078-0432.CCR-18-3535","article-title":"Unexpected activities in regulating ciliation contribute to off-target effects of targeted drugs","volume":"25","author":"Kiseleva","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.cellsig.2019.109497_bb0705","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1091\/mbc.10.5.1621","article-title":"Endocytosis deficiency of epidermal growth factor (EGF) receptor-ErbB2 heterodimers in response to EGF stimulation","volume":"10","author":"Wang","year":"1999","journal-title":"Mol. Biol. Cell"},{"issue":"8","key":"10.1016\/j.cellsig.2019.109497_bb0710","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1681\/ASN.V181048","article-title":"Elevated proto-oncogene expression in polycystic kidneys of the C57BL\/6J (cpk) mouse","volume":"1","author":"Cowley","year":"1991","journal-title":"J. Am. Soc. Nephrol."},{"issue":"4","key":"10.1016\/j.cellsig.2019.109497_bb0715","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1681\/ASN.2004121090","article-title":"Effectiveness of vasopressin V2 receptor antagonists OPC-31260 and OPC-41061 on polycystic kidney disease development in the PCK rat","volume":"16","author":"Wang","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"issue":"49","key":"10.1016\/j.cellsig.2019.109497_bb0720","doi-asserted-by":"crossref","first-page":"31296","DOI":"10.1016\/S0021-9258(18)47422-4","article-title":"Sequential activation of Raf-1 kinase, mitogen-activated protein (MAP) kinase kinase, MAP kinase, and S6 kinase by hyperosmolality in renal cells","volume":"269","author":"Terada","year":"1994","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.cellsig.2019.109497_bb0725","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1046\/j.1523-1755.2003.00755.x","article-title":"Renal activation of extracellular signal-regulated kinase in rats with autosomal-dominant polycystic kidney disease","volume":"63","author":"Nagao","year":"2003","journal-title":"Kidney Int."},{"issue":"6","key":"10.1016\/j.cellsig.2019.109497_bb0730","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1681\/ASN.2004090800","article-title":"Extracellular signal-regulated kinase inhibition slows disease progression in mice with polycystic kidney disease","volume":"17","author":"Omori","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"issue":"11","key":"10.1016\/j.cellsig.2019.109497_bb0735","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1093\/hmg\/ddn039","article-title":"Cyst formation and activation of the extracellular regulated kinase pathway after kidney specific inactivation of Pkd1","volume":"17","author":"Shibazaki","year":"2008","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.1016\/j.cellsig.2019.109497_bb0740","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0925-4439(00)00079-X","article-title":"Modification of the composition of polycystin-1 multiprotein complexes by calcium and tyrosine phosphorylation","volume":"1535","author":"Geng","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.cellsig.2019.109497_bb0745","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1006\/bbrc.1999.0780","article-title":"Identification of phosphorylation sites in the PKD1-encoded protein C-terminal domain","volume":"259","author":"Li","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"10","key":"10.1016\/j.cellsig.2019.109497_bb0750","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.bbadis.2010.11.006","article-title":"Receptor protein tyrosine phosphatases are novel components of a polycystin complex","volume":"1812","author":"Boucher","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"issue":"7","key":"10.1016\/j.cellsig.2019.109497_bb0755","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1681\/ASN.V1171179","article-title":"cAMP regulates cell proliferation and cyst formation in autosomal polycystic kidney disease cells","volume":"11","author":"Hanaoka","year":"2000","journal-title":"J. Am. Soc. Nephrol."},{"issue":"7","key":"10.1016\/j.cellsig.2019.109497_bb0760","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1681\/ASN.2007060665","article-title":"Src inhibition ameliorates polycystic kidney disease","volume":"19","author":"Sweeney","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"issue":"35","key":"10.1016\/j.cellsig.2019.109497_bb0765","doi-asserted-by":"crossref","first-page":"12859","DOI":"10.1073\/pnas.1405362111","article-title":"Nedd9 restrains renal cystogenesis in Pkd1-\/- mice","volume":"111","author":"Nikonova","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.cellsig.2019.109497_bb0770","doi-asserted-by":"crossref","first-page":"C522","DOI":"10.1152\/ajpcell.00163.2010","article-title":"c-Src inactivation reduces renal epithelial cell-matrix adhesion, proliferation, and cyst formation","volume":"301","author":"Elliott","year":"2011","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"1","key":"10.1016\/j.cellsig.2019.109497_bb0775","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S1097-2765(01)00432-4","article-title":"PKA phosphorylation of Src mediates cAMP's inhibition of cell growth via Rap1","volume":"9","author":"Schmitt","year":"2002","journal-title":"Mol. Cell"},{"issue":"9","key":"10.1016\/j.cellsig.2019.109497_bb0780","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/onc.2014.41","article-title":"PKA signaling drives mammary tumorigenesis through Src","volume":"34","author":"Beristain","year":"2015","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.cellsig.2019.109497_bb0785","doi-asserted-by":"crossref","first-page":"F677","DOI":"10.1152\/ajprenal.00119.2017","article-title":"The regulatory 1alpha subunit of protein kinase A modulates renal cystogenesis","volume":"313","author":"Ye","year":"2017","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"24","key":"10.1016\/j.cellsig.2019.109497_bb0790","doi-asserted-by":"crossref","first-page":"8414","DOI":"10.1128\/MCB.21.24.8414-8427.2001","article-title":"Nerve growth factor stimulates multisite tyrosine phosphorylation and activation of the atypical protein kinase C\u2019s via a src kinase pathway","volume":"21","author":"Wooten","year":"2001","journal-title":"Mol. Cell. Biol."},{"issue":"2","key":"10.1016\/j.cellsig.2019.109497_bb0795","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.devcel.2010.07.009","article-title":"MIM and cortactin antagonism regulates ciliogenesis and hedgehog signaling","volume":"19","author":"Bershteyn","year":"2010","journal-title":"Dev. Cell"},{"issue":"9","key":"10.1016\/j.cellsig.2019.109497_bb0800","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1083\/jcb.201703196","article-title":"Actin polymerization controls cilia-mediated signaling","volume":"217","author":"Drummond","year":"2018","journal-title":"J. Cell Biol."},{"issue":"8","key":"10.1016\/j.cellsig.2019.109497_bb0805","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0183030","article-title":"Jasplakinolide induces primary cilium formation through cell rounding and YAP inactivation","volume":"12","author":"Nagai","year":"2017","journal-title":"PLoS ONE"},{"issue":"17","key":"10.1016\/j.cellsig.2019.109497_bb0810","doi-asserted-by":"crossref","first-page":"11960","DOI":"10.1074\/jbc.M112.415075","article-title":"Increased activity of the vesicular soluble N-ethylmaleimide-sensitive factor attachment protein receptor TI-VAMP\/VAMP7 by tyrosine phosphorylation in the Longin domain","volume":"288","author":"Burgo","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"24","key":"10.1016\/j.cellsig.2019.109497_bb0815","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.222034","article-title":"An interaction network between the SNARE VAMP7 and Rab GTPases within a ciliary membrane-targeting complex","volume":"131","author":"Kandachar","year":"2018","journal-title":"J. Cell Sci."},{"issue":"Pt 8","key":"10.1016\/j.cellsig.2019.109497_bb0820","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1242\/jcs.039446","article-title":"Adhesion signaling \u2013 crosstalk between integrins, Src and Rho","volume":"122","author":"Huveneers","year":"2009","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.cellsig.2019.109497_bb0825","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ceb.2017.12.003","article-title":"EGFR family and Src family kinase interactions: mechanics matters?","volume":"51","author":"Chen","year":"2018","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.cellsig.2019.109497_bb0830","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/978-3-319-51436-9_12","article-title":"Inflammation and fibrosis in polycystic kidney disease","volume":"60","author":"Song","year":"2017","journal-title":"Results Probl. Cell Differ."},{"issue":"2","key":"10.1016\/j.cellsig.2019.109497_bb0835","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1681\/ASN.2011070645","article-title":"EGFR signaling promotes TGFbeta-dependent renal fibrosis","volume":"23","author":"Chen","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"issue":"5","key":"10.1016\/j.cellsig.2019.109497_bb0840","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1681\/ASN.2011050493","article-title":"Genetic or pharmacologic blockade of EGFR inhibits renal fibrosis","volume":"23","author":"Liu","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"issue":"10174","key":"10.1016\/j.cellsig.2019.109497_bb0845","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0140-6736(18)32782-X","article-title":"Autosomal dominant polycystic kidney disease","volume":"393","author":"Cornec-Le Gall","year":"2019","journal-title":"Lancet (London, England)"},{"issue":"1","key":"10.1016\/j.cellsig.2019.109497_bb0850","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1365-2796.2006.01743.x","article-title":"Polycystic kidney disease: genes, proteins, animal models, disease mechanisms and therapeutic opportunities","volume":"261","author":"Torres","year":"2007","journal-title":"J. Intern. Med."},{"issue":"4","key":"10.1016\/j.cellsig.2019.109497_bb0855","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1046\/j.1523-1755.2003.00232.x","article-title":"Combination treatment of PKD utilizing dual inhibition of EGF-receptor activity and ligand bioavailability","volume":"64","author":"Sweeney","year":"2003","journal-title":"Kidney Int."},{"issue":"5","key":"10.1016\/j.cellsig.2019.109497_bb0860","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1111\/j.1523-1755.2004.00952.x","article-title":"Epidermal growth factor receptor tyrosine kinase inhibition is not protective in PCK rats","volume":"66","author":"Torres","year":"2004","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.cellsig.2019.109497_bb0865","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.1523-1755.2000.00829.x","article-title":"Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitor","volume":"57","author":"Sweeney","year":"2000","journal-title":"Kidney Int."},{"key":"10.1016\/j.cellsig.2019.109497_bb0870","doi-asserted-by":"crossref","first-page":"228","DOI":"10.3389\/fonc.2015.00228","article-title":"Opposing effects of inhibitors of Aurora-A and EGFR in autosomal-dominant polycystic kidney disease","volume":"5","author":"Nikonova","year":"2015","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.cellsig.2019.109497_bb0875","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1177\/1947601911411084","article-title":"Ras in cancer and developmental diseases","volume":"2","author":"Fernandez-Medarde","year":"2011","journal-title":"Genes Cancer"},{"issue":"22","key":"10.1016\/j.cellsig.2019.109497_bb0880","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1038\/sj.onc.1210422","article-title":"Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer","volume":"26","author":"Roberts","year":"2007","journal-title":"Oncogene"},{"issue":"11","key":"10.1016\/j.cellsig.2019.109497_bb0885","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nrd.2016.139","article-title":"Direct small-molecule inhibitors of KRAS: from structural insights to mechanism-based design","volume":"15","author":"Ostrem","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"issue":"11","key":"10.1016\/j.cellsig.2019.109497_bb0890","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.1093\/ndt\/gfr432","article-title":"The Raf kinase inhibitor PLX5568 slows cyst proliferation in rat polycystic kidney disease but promotes renal and hepatic fibrosis","volume":"26","author":"Buchholz","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"issue":"11","key":"10.1016\/j.cellsig.2019.109497_bb0895","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1681\/ASN.2016111232","article-title":"Bosutinib versus placebo for autosomal dominant polycystic kidney disease","volume":"28","author":"Tesar","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"issue":"4","key":"10.1016\/j.cellsig.2019.109497_bb0900","doi-asserted-by":"crossref","first-page":"188","DOI":"10.5527\/wjn.v6.i4.188","article-title":"Tesevatinib ameliorates progression of polycystic kidney disease in rodent models of autosomal recessive polycystic kidney disease","volume":"6","author":"Sweeney","year":"2017","journal-title":"World J Nephrol"},{"issue":"1","key":"10.1016\/j.cellsig.2019.109497_bb0905","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-03117-y","article-title":"EGF receptor kinase suppresses ciliogenesis through activation of USP8 deubiquitinase","volume":"9","author":"Kasahara","year":"2018","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.cellsig.2019.109497_bb0910","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/s41568-018-0023-6","article-title":"Ciliary signalling in cancer","volume":"18","author":"Liu","year":"2018","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.cellsig.2019.109497_bb0915","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1681\/ASN.2013101138","article-title":"Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trials","volume":"26","author":"Irazabal","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.cellsig.2019.109497_bb0920","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1161\/HYPERTENSIONAHA.117.09843","article-title":"Selective nanoparticle targeting of the renal tubules","volume":"71","author":"Williams","year":"2018","journal-title":"Hypertension"},{"issue":"9","key":"10.1016\/j.cellsig.2019.109497_bb0925","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.1172\/JCI127511","article-title":"The archaeal Dps nanocage targets kidney proximal tubules via glomerular filtration","volume":"129","author":"Uchida","year":"2019","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.cellsig.2019.109497_bb0930","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/gt.2014.35","article-title":"rAAV9 combined with renal vein injection is optimal for kidney-targeted gene delivery: conclusion of a comparative study","volume":"21","author":"Rocca","year":"2014","journal-title":"Gene Ther."}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656819302931?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656819302931?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T10:52:51Z","timestamp":1760266371000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656819302931"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":186,"alternative-id":["S0898656819302931"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2019.109497","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proliferative signaling by ERBB proteins and RAF\/MEK\/ERK effectors in polycystic kidney disease","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2019.109497","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109497"}}